Titan Pharmaceuticals
TTNP
#10474
Rank
โ‚น0.57 B
Marketcap
โ‚น433.26
Share price
-3.76%
Change (1 day)
27.59%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น412.59. In 2023 the company made an earnings per share (EPS) of -โ‚น696.41 an increase over its 2022 EPS that were of -โ‚น1,428.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น696.41-51.22%
2022-โ‚น1,428-15.61%
2021-โ‚น1,692-81.37%
2020-โ‚น9,079-77.52%
2019-โ‚น40,394-56.32%
2018-โ‚น92,480-59.51%
2017-โ‚น2,28,426-371.81%
2016โ‚น84,038-144.35%
2015-โ‚น1,89,471300%
2014-โ‚น47,368-121.54%
2013โ‚น2,19,922-151.38%
2012-โ‚น4,28,002-11.54%
2011-โ‚น4,83,829188.89%
2010-โ‚น1,67,479-10%
2009-โ‚น1,86,088
2007-โ‚น7,62,961-2.38%
2006-โ‚น7,81,570-39.13%
2005-โ‚น12,84,007-16.87%
2004-โ‚น15,44,531-22.43%
2003-โ‚น19,91,1424.9%
2002-โ‚น18,98,09861.9%
2001-โ‚น11,72,355-13.7%
2000-โ‚น13,58,44365.01%
1999-โ‚น8,23,262-35.87%
1998-โ‚น12,83,788-1824.71%
1997โ‚น74,435-102.4%
1996-โ‚น31,07,670

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,047-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น691.71-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น133.46-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.82-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.50-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น317.66-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA